The Differences in the Psychological States of Patients with Different Chronic Hip Pain

A Clinical Retrospective Cross-sectional Study of the Differences in the Psychological States of Patients with Different Chronic Hip Pain

Nowadays, studies related to the psychological state of patients with chronic hip pain are still limited, and there is a lack of research on the characteristics of the psychological state of patients with chronic soreness from different pain sources. The goal of this retrospective cross-sectional study was to reveal differences between the psychological states of chronic hip pain patients with different pain sources. The main question it aims to answer is whether there are differences in psychological states among hip pain patients with intra-hip pain, extra-hip pain, and intra-hip combined with extra-hip pain.

Study Overview

• Status: Enrolling by invitation
• Conditions: Hip Pain Chronic; Psychological Disorders
• Intervention / Treatment: Other: Psychological and Functional Assessment

• Study Type: Observational
• Enrollment (Estimated): 70

Contacts and Locations

Study Locations

• China
  • Beijing
    • Beijing, Beijing, China, 100000
      • General Hospital of the Chinese People's Liberation Army

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult; Older Adult
• Accepts Healthy Volunteers: No

• Sampling Method: Probability Sample

Study Population

Patients with chronic hip pain who visited the hip joint specialist outpatient clinic of the PLA General Hospital were included in the study. The diagnosis was made by the same docter based on clinical and radiological examinations, with a clear diagnosis of hip disease. Patients were divided into three groups according to the source of pain: intra-articular pain group, extra-articular pain group, and intra-articular combined extra-articular pain group. Intra-articular hip pain encompasses a range of conditions, including femoral acetabular impingement (FAI) and labral damage within the hip joint. Extra-articular hip pain encompasses conditions such as trochanteric bursitis and gluteal fasciitis. Combined hip pain represents a combination of both of these etiological factors.

Description

Inclusion Criteria:

• The subject must be at least 16 years old and of sound mind；
• Chronic hip pain persisting for a duration exceeding 3 months.

Exclusion Criteria:

• Previous mental illness and cognitive impairment；
• Other serious illnesses such as heart failure, respiratory failure, malignant tumours, severe trauma and other serious illnesses;；
• Chronic pain lasting for more than 3 months in other parts of the body;；
• Use of prescribed opioid drugs exceeding 60 mg morphine equivalent per day or steroid analgesics.

Study Plan

How is the study designed?

Number of groups / cohorts

3

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
intra-articular hip pain group	Other: Psychological and Functional Assessment; Assessment of Pain Sources: Patients are grouped based on intra-articular, extra-articular, or combined intra- and extra-articular hip pain.Psychological Assessment: Depression and anxiety are assessed using standardized questionnaires (e.g., BDI for depression, SAS for anxiety).Functional Assessment: Joint function and pain are evaluated using clinical and patient-reported outcome measures.
extra-articular hip pain group	Other: Psychological and Functional Assessment; Assessment of Pain Sources: Patients are grouped based on intra-articular, extra-articular, or combined intra- and extra-articular hip pain.Psychological Assessment: Depression and anxiety are assessed using standardized questionnaires (e.g., BDI for depression, SAS for anxiety).Functional Assessment: Joint function and pain are evaluated using clinical and patient-reported outcome measures.
intra-articular combined extra-articular hip pain group	Other: Psychological and Functional Assessment; Assessment of Pain Sources: Patients are grouped based on intra-articular, extra-articular, or combined intra- and extra-articular hip pain.Psychological Assessment: Depression and anxiety are assessed using standardized questionnaires (e.g., BDI for depression, SAS for anxiety).Functional Assessment: Joint function and pain are evaluated using clinical and patient-reported outcome measures.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
the Beck Depression Inventory (BDI)	The BDI is a self-assessment scale that has been demonstrated to be a reliable and valid tool for evaluating depressive symptoms. The BDI comprises 21 items, each item is assigned a score on a scale of 0 to 3, with higher scores indicating a greater severity of depressive symptoms.	5 minutes
the Zung Self-Rating Anxiety Scale (SAS)	The SAS is a self-assessment instrument designed to evaluate the presence and severity of anxiety symptoms. The SAS consists of 20 items, each item consisting of four statements, and each item is scored on a scale of 1 to 4. A higher score indicates a higher level of anxiety.	5 minutes

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
the Visual Analogue Scale (VAS)	for the assessment of the level of hip pain perceived by the patient	2 minutes
the Pain Sensitivity Questionnaire (PSQ)	for the assessment of the individual's sensitivity to pain	5 minutes
The Hip Outcome Score Activities of Daily Living (HOS-ADL)	evaluate the functional activities necessitated by daily life with the hip	5 minutes
The Hip Outcome Score - Sport-specific subscale (HOS-SSS)	assess the capacity to perform sports activities	5 minutes
the modified Harris Hip Score (mHHS)	assess the functional level of the hip joint	5 minutes
the international hip outcome tool (IHOT-12)	assess the functional level of the hip joint	5 minutes

Collaborators and Investigators

• Sponsor: ChunBao Li
• Investigators: Study Director: Chunbao Li, The Fourth Medical Centre of the General Hospital of the People's Liberation Army

Study record dates

Study Major Dates

• Study Start (Actual): December 5, 2023
• Primary Completion (Estimated): October 1, 2024
• Study Completion (Estimated): October 1, 2024

Study Registration Dates

• First Submitted: September 22, 2024
• First Submitted That Met QC Criteria: September 22, 2024
• First Posted (Actual): September 25, 2024

Study Record Updates

• Last Update Posted (Actual): September 26, 2024
• Last Update Submitted That Met QC Criteria: September 24, 2024
• Last Verified: September 1, 2024

More Information

Terms related to this study

• Keywords: pain; depression; anxiety; hip; Psychological Disorders
• Additional Relevant MeSH Terms: Mental Disorders
• Other Study ID Numbers: 2023KY031-KS001

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No